Skip to main content
Top
Published in: World Journal of Surgery 9/2008

01-09-2008

Impact of the Degree of Liver Resection on Survival for Patients with Multiple Liver Metastases from Colorectal Cancer

Authors: Kuniya Tanaka, Hiroshi Shimada, Chizuru Matsumoto, Kenichi Matsuo, Kazuhisa Takeda, Yasuhiko Nagano, Shinji Togo

Published in: World Journal of Surgery | Issue 9/2008

Login to get access

Abstract

Background

Although the degree of hepatic resection has been found to be a key aspect of tumor stimulation, the differences in clinical outcome between a massive liver resection and a less extensive resection for multiple colorectal metastases have not been well studied. The purpose of this study was to clarify the impact of the extent of liver resection on survival outcome.

Methods

Clinicopathologic data were available for 85 patients who were surgically treated for four or more liver metastases. Forty-nine patients who underwent a major hepatic resection were compared with patients who underwent minor hepatic resections (n = 36).

Results

As the patients undergoing major resection were more likely to have multiple (p = 0.014) and large tumors (p = 0.021) compared to the minor-resection patients, their overall survival was worse (p = 0.046) and the disease-free rate tended to be poorer. By multivariate analysis of the cohorts, the only independent factor affecting survival was the number of liver tumors (≤5 or ≥6; relative risk [RR] = 0.427; p = 0.014). When patients with six or more metastases were selected and analyzed, the overall survival of patients who had a major resection was significantly poorer than those who had minor resections (p = 0.028), although the clinical characteristics were comparable between the two groups.

Conclusion

Although the extent of hepatectomy was not an independent prognosticator, minor resections for multiple colorectal metastases may offer a long-term survival advantage compared to a major resection.
Literature
1.
go back to reference Registry of Hepatic Metastases (1988) Resection of the liver for colorectal carcinoma metastases: a multiinstitutional study of indications for resection. Surgery 103:278–288 Registry of Hepatic Metastases (1988) Resection of the liver for colorectal carcinoma metastases: a multiinstitutional study of indications for resection. Surgery 103:278–288
2.
go back to reference Minagawa M, Makuuchi M, Torzilli G et al (2000) Extension of the frontiers of surgical indications in the treatment of liver metastases from colorectal cancer: long-term results. Ann Surg 231:487–499PubMedCrossRef Minagawa M, Makuuchi M, Torzilli G et al (2000) Extension of the frontiers of surgical indications in the treatment of liver metastases from colorectal cancer: long-term results. Ann Surg 231:487–499PubMedCrossRef
3.
go back to reference Shaw IM, Rees M, Welsh KS et al (2006) Repeat hepatic resection for recurrent colorectal liver metastases is associated with favorable long-term survival. Br J Surg 93:457–464PubMedCrossRef Shaw IM, Rees M, Welsh KS et al (2006) Repeat hepatic resection for recurrent colorectal liver metastases is associated with favorable long-term survival. Br J Surg 93:457–464PubMedCrossRef
4.
go back to reference Arru M, Aldrighetti L, Castoldi R et al (2007) Analysis of prognostic factors influencing long-term survival after hepatic resection for metastatic colorectal cancer. World J Surg 32:93–103CrossRef Arru M, Aldrighetti L, Castoldi R et al (2007) Analysis of prognostic factors influencing long-term survival after hepatic resection for metastatic colorectal cancer. World J Surg 32:93–103CrossRef
5.
go back to reference Fortner JG, Silva JS, Golbey RB et al (1984) Multivariate analysis of a personal series of 247 consecutive patients with liver metastases from colorectal cancer. I. Treatment by hepatic resection. Ann Surg 199:306–316PubMedCrossRef Fortner JG, Silva JS, Golbey RB et al (1984) Multivariate analysis of a personal series of 247 consecutive patients with liver metastases from colorectal cancer. I. Treatment by hepatic resection. Ann Surg 199:306–316PubMedCrossRef
6.
go back to reference August DA, Ottow RT, Sugarbaker PH (1984) Clinical perspective of human colorectal cancer metastasis. Cancer Metastasis Rev 3:303–324PubMedCrossRef August DA, Ottow RT, Sugarbaker PH (1984) Clinical perspective of human colorectal cancer metastasis. Cancer Metastasis Rev 3:303–324PubMedCrossRef
7.
go back to reference Broering DC, Hillert C, Krupski G et al (2002) Portal vein embolization vs. portal vein ligation for induction of hypertrophy of the future liver remnant. J Gastrointest Surg 6:905–913PubMedCrossRef Broering DC, Hillert C, Krupski G et al (2002) Portal vein embolization vs. portal vein ligation for induction of hypertrophy of the future liver remnant. J Gastrointest Surg 6:905–913PubMedCrossRef
8.
go back to reference Abdalla EK, Hicks ME, Vauthey JN (2001) Portal vein embolization: rationale, technique and future prospects. Br J Surg 88:165–175PubMedCrossRef Abdalla EK, Hicks ME, Vauthey JN (2001) Portal vein embolization: rationale, technique and future prospects. Br J Surg 88:165–175PubMedCrossRef
9.
go back to reference Athoulay D, Castaing D, Smail A et al (2000) Resection of nonresectable liver metastases from colorectal cancer after percutaneous portal vein embolization. Ann Surg 231:480–486CrossRef Athoulay D, Castaing D, Smail A et al (2000) Resection of nonresectable liver metastases from colorectal cancer after percutaneous portal vein embolization. Ann Surg 231:480–486CrossRef
10.
go back to reference Adam R, Laurent A, Azoulay D et al (2000) Two-stage hepatectomy: a planned strategy to treat irresectable liver tumors. Ann Surg 232:777–785PubMedCrossRef Adam R, Laurent A, Azoulay D et al (2000) Two-stage hepatectomy: a planned strategy to treat irresectable liver tumors. Ann Surg 232:777–785PubMedCrossRef
11.
go back to reference Kianmanesh R, Farges O, Abdalla EK et al (2003) Right portal vein ligation: a new planned two-step all-surgical approach for complete resection of primary gastrointestinal tumors with multiple bilateral liver metastases. J Am Coll Surg 197:164–170PubMedCrossRef Kianmanesh R, Farges O, Abdalla EK et al (2003) Right portal vein ligation: a new planned two-step all-surgical approach for complete resection of primary gastrointestinal tumors with multiple bilateral liver metastases. J Am Coll Surg 197:164–170PubMedCrossRef
12.
go back to reference Ikeda Y, Matsumata T, Takenaka K et al (1995) Preliminary report of tumor metastasis during liver regeneration after hepatic resection in rats. Eur J Surg Oncol 21:188–190PubMedCrossRef Ikeda Y, Matsumata T, Takenaka K et al (1995) Preliminary report of tumor metastasis during liver regeneration after hepatic resection in rats. Eur J Surg Oncol 21:188–190PubMedCrossRef
13.
go back to reference Mizutani J, Hiraoka T, Yamashita R et al (1992) Promotion of hepatic metastases by liver resection in the rat. Br J Cancer 65:794–797PubMed Mizutani J, Hiraoka T, Yamashita R et al (1992) Promotion of hepatic metastases by liver resection in the rat. Br J Cancer 65:794–797PubMed
14.
go back to reference Jiang W, Hiscox S, Matsumoto K et al (1999) Hepatocyte growth factor/scatter factor, its molecular, cellular and clinical implications in cancer. Crit Rev Oncol Hematol 29:209–248PubMedCrossRef Jiang W, Hiscox S, Matsumoto K et al (1999) Hepatocyte growth factor/scatter factor, its molecular, cellular and clinical implications in cancer. Crit Rev Oncol Hematol 29:209–248PubMedCrossRef
15.
go back to reference Lukomska B, Dluzniewska J, Polanski J et al (2004) Expression of growth factors in colorectal carcinoma liver metastatic patients after partial hepatectomy: implications for a functional role in cell proliferation during liver regeneration. Comp Hepatol 3(Suppl 1):S52PubMedCrossRef Lukomska B, Dluzniewska J, Polanski J et al (2004) Expression of growth factors in colorectal carcinoma liver metastatic patients after partial hepatectomy: implications for a functional role in cell proliferation during liver regeneration. Comp Hepatol 3(Suppl 1):S52PubMedCrossRef
16.
go back to reference Yoon SS, Kim SH, Gonen M et al (2006) Profile of plasma angiogenic factors before and after hepatectomy for colorectal cancer liver metastases. Ann Surg Oncol 13:353–362PubMedCrossRef Yoon SS, Kim SH, Gonen M et al (2006) Profile of plasma angiogenic factors before and after hepatectomy for colorectal cancer liver metastases. Ann Surg Oncol 13:353–362PubMedCrossRef
17.
go back to reference Hemming AW, Reed AI, Howard RJ et al (2003) Preoperative portal vein embolization for extended hepatectomy. Ann Surg 237:686–693PubMedCrossRef Hemming AW, Reed AI, Howard RJ et al (2003) Preoperative portal vein embolization for extended hepatectomy. Ann Surg 237:686–693PubMedCrossRef
18.
go back to reference Barbaro B, Di Stasi C, Nuzzo G et al (2003) Preoperative right portal vein embolization in patients with metastatic liver disease. Metastatic liver volumes after RPVE. Acta Radiol 44:98–102PubMedCrossRef Barbaro B, Di Stasi C, Nuzzo G et al (2003) Preoperative right portal vein embolization in patients with metastatic liver disease. Metastatic liver volumes after RPVE. Acta Radiol 44:98–102PubMedCrossRef
19.
go back to reference Kokudo N, Tada K, Seki M et al (2001) Proliferative activity of intrahepatic colorectal metastases after preoperative hemihepatic portal vein embolization. Hepatology 34:267–272PubMedCrossRef Kokudo N, Tada K, Seki M et al (2001) Proliferative activity of intrahepatic colorectal metastases after preoperative hemihepatic portal vein embolization. Hepatology 34:267–272PubMedCrossRef
20.
go back to reference Yamanaka N, Okamoto E, Oriyama T et al (1994) A prediction scoring system to select the surgical treatment of liver cancer. Further refinement based on 10 years of use. Ann Surg 219:342–346PubMedCrossRef Yamanaka N, Okamoto E, Oriyama T et al (1994) A prediction scoring system to select the surgical treatment of liver cancer. Further refinement based on 10 years of use. Ann Surg 219:342–346PubMedCrossRef
21.
go back to reference The Brisbane (2000) Terminology of Liver Anatomy and Resection (2000) Terminology Committee of the International Hepato-Pancreato-Biliary Association. HPB 2:333–339 The Brisbane (2000) Terminology of Liver Anatomy and Resection (2000) Terminology Committee of the International Hepato-Pancreato-Biliary Association. HPB 2:333–339
22.
go back to reference Elias D, Ouellet JF, Bellon N et al (2003) Extrahepatic disease does not contraindicate hepatectomy for colorectal liver metastases. Br J Surg 90:567–574PubMedCrossRef Elias D, Ouellet JF, Bellon N et al (2003) Extrahepatic disease does not contraindicate hepatectomy for colorectal liver metastases. Br J Surg 90:567–574PubMedCrossRef
23.
go back to reference Harun N, Nikfarjam M, Muralidharan V et al (2007) Liver regeneration stimulates tumor metastases. J Surg Res 138:284–290PubMedCrossRef Harun N, Nikfarjam M, Muralidharan V et al (2007) Liver regeneration stimulates tumor metastases. J Surg Res 138:284–290PubMedCrossRef
24.
go back to reference Jiang WG, Hallett MB, Puntis MC (1993) Hepatocyte growth factor/scatter factor, liver regeneration and cancer metastasis. Br J Surg 80:1368–1373PubMedCrossRef Jiang WG, Hallett MB, Puntis MC (1993) Hepatocyte growth factor/scatter factor, liver regeneration and cancer metastasis. Br J Surg 80:1368–1373PubMedCrossRef
25.
go back to reference Castillo MH, Doerr RJ, Paolini N Jr et al (1989) Hepatectomy prolongs survival of mice with induced liver metastases. Arch Surg 124:167–169PubMed Castillo MH, Doerr RJ, Paolini N Jr et al (1989) Hepatectomy prolongs survival of mice with induced liver metastases. Arch Surg 124:167–169PubMed
26.
go back to reference Doerr R, Castillo M, Evans P et al (1989) Partial hepatectomy augments the liver’s antitumor response. Arch Surg 124:170–174PubMed Doerr R, Castillo M, Evans P et al (1989) Partial hepatectomy augments the liver’s antitumor response. Arch Surg 124:170–174PubMed
27.
go back to reference Ono M, Tanaka N, Orita K (1986) Complete regression of mouse hepatoma transplanted after partial hepatectomy and the immunological mechanism of such regression. Cancer Res 46:5049–5053PubMed Ono M, Tanaka N, Orita K (1986) Complete regression of mouse hepatoma transplanted after partial hepatectomy and the immunological mechanism of such regression. Cancer Res 46:5049–5053PubMed
29.
go back to reference Mangnall D, Bird NC, Majeed AW (2003) The molecular physiology of liver regeneration following partial hepatectomy. Liver Int 23:124–138PubMedCrossRef Mangnall D, Bird NC, Majeed AW (2003) The molecular physiology of liver regeneration following partial hepatectomy. Liver Int 23:124–138PubMedCrossRef
30.
go back to reference Elias D, De Baere T, Roche A et al (1999) During liver regeneration following right portal embolization the growth rate of liver metastases is more rapid than that of the liver parenchyma. Br J Surg 86:784–788PubMedCrossRef Elias D, De Baere T, Roche A et al (1999) During liver regeneration following right portal embolization the growth rate of liver metastases is more rapid than that of the liver parenchyma. Br J Surg 86:784–788PubMedCrossRef
31.
go back to reference Nordlinger B, Guiguet M, Vaillant JC et al (1996) Surgical resection of colorectal carcinoma metastases to the liver: a prognostic scoring system to improve case selection, based on 1568 patients. Cancer 77:1254–1262PubMedCrossRef Nordlinger B, Guiguet M, Vaillant JC et al (1996) Surgical resection of colorectal carcinoma metastases to the liver: a prognostic scoring system to improve case selection, based on 1568 patients. Cancer 77:1254–1262PubMedCrossRef
32.
go back to reference Tanaka K, Shimada H, Kubota K et al (2005) Effectiveness of prehepatectomy intra-arterial chemotherapy for multiple bilobar colorectal cancer metastases to the liver: a clinicopathologic study of peritumoral vasculobiliary invasion. Surgery 137:156–164PubMedCrossRef Tanaka K, Shimada H, Kubota K et al (2005) Effectiveness of prehepatectomy intra-arterial chemotherapy for multiple bilobar colorectal cancer metastases to the liver: a clinicopathologic study of peritumoral vasculobiliary invasion. Surgery 137:156–164PubMedCrossRef
33.
go back to reference Kornprat P, Jarnagin WR, Gonen M et al (2007) Outcome after hepatectomy for multiple (four or more) colorectal metastases in the era of effective chemotherapy. Ann Surg Oncol 14:1151–1160PubMedCrossRef Kornprat P, Jarnagin WR, Gonen M et al (2007) Outcome after hepatectomy for multiple (four or more) colorectal metastases in the era of effective chemotherapy. Ann Surg Oncol 14:1151–1160PubMedCrossRef
34.
go back to reference Weber SM, Jarnagin WR, DeMatteo RP et al (2000) Survival after resection of multiple hepatic colorectal metastases. Ann Surg Oncol 7:643–650PubMedCrossRef Weber SM, Jarnagin WR, DeMatteo RP et al (2000) Survival after resection of multiple hepatic colorectal metastases. Ann Surg Oncol 7:643–650PubMedCrossRef
35.
go back to reference Abdalla EK, Vauthey JN, Ellis LM et al (2004) Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases. Ann Surg 239:818–827PubMedCrossRef Abdalla EK, Vauthey JN, Ellis LM et al (2004) Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases. Ann Surg 239:818–827PubMedCrossRef
36.
go back to reference Tanaka K, Shimada H, Nagano Y et al (2006) Outcome after hepatic resection versus combined resection and microwave ablation for multiple bilobar colorectal metastases to the liver. Surgery 139:263–273PubMedCrossRef Tanaka K, Shimada H, Nagano Y et al (2006) Outcome after hepatic resection versus combined resection and microwave ablation for multiple bilobar colorectal metastases to the liver. Surgery 139:263–273PubMedCrossRef
37.
go back to reference Giacchetti S, Perpoint B, Zidani R et al (2000) Phase III multicenter randomized trial of oxaliplatin added to chronomodulated fluorouracil-leucovorin as first-line treatment of metastatic colorectal cancer. J Clin Oncol 18:136–147PubMed Giacchetti S, Perpoint B, Zidani R et al (2000) Phase III multicenter randomized trial of oxaliplatin added to chronomodulated fluorouracil-leucovorin as first-line treatment of metastatic colorectal cancer. J Clin Oncol 18:136–147PubMed
38.
go back to reference Douillard JY, Cunningham D, Roth AD et al (2000) Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial. Lancet 355:1041–1047PubMedCrossRef Douillard JY, Cunningham D, Roth AD et al (2000) Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial. Lancet 355:1041–1047PubMedCrossRef
39.
go back to reference Bismuth H, Adam R, Levi F et al (1996) Resection of nonresectable liver metastases from colorectal cancer after neoadjuvant chemotherapy. Ann Surg 224:509–520PubMedCrossRef Bismuth H, Adam R, Levi F et al (1996) Resection of nonresectable liver metastases from colorectal cancer after neoadjuvant chemotherapy. Ann Surg 224:509–520PubMedCrossRef
40.
go back to reference Adam R, Avisar E, Ariche A et al (2001) Five-year survival following hepatic resection after neoadjuvant therapy for nonresectable colorectal [liver] metastases. Ann Surg Oncol 8:347–353PubMedCrossRef Adam R, Avisar E, Ariche A et al (2001) Five-year survival following hepatic resection after neoadjuvant therapy for nonresectable colorectal [liver] metastases. Ann Surg Oncol 8:347–353PubMedCrossRef
41.
go back to reference Parikh AA, Gentner B, Wu TT et al (2003) Perioperative complications in patients undergoing major liver resection with or without neoadjuvant chemotherapy. J Gastrointest Surg 7:1082–1088PubMedCrossRef Parikh AA, Gentner B, Wu TT et al (2003) Perioperative complications in patients undergoing major liver resection with or without neoadjuvant chemotherapy. J Gastrointest Surg 7:1082–1088PubMedCrossRef
42.
go back to reference Tanaka K, Shimada H, Ueda M et al (2006) Perioperative complications after hepatectomy with or without intra-arterial chemotherapy for bilobar colorectal cancer liver metastases. Surgery 139:599–607PubMedCrossRef Tanaka K, Shimada H, Ueda M et al (2006) Perioperative complications after hepatectomy with or without intra-arterial chemotherapy for bilobar colorectal cancer liver metastases. Surgery 139:599–607PubMedCrossRef
43.
go back to reference Karoui M, Penna C, Amin-Hashem M et al (2006) Influence of preoperative chemotherapy on the risk of major hepatectomy for colorectal liver metastases. Ann Surg 243:1–7PubMedCrossRef Karoui M, Penna C, Amin-Hashem M et al (2006) Influence of preoperative chemotherapy on the risk of major hepatectomy for colorectal liver metastases. Ann Surg 243:1–7PubMedCrossRef
44.
go back to reference Lorenz M, Müller H, Schramm H et al (1998) Randomized trial of surgery versus surgery followed by adjuvant hepatic arterial infusion with 5-fluorouracil and folinic acid for liver metastases of colorectal cancer. Ann Surg 228:756–764PubMedCrossRef Lorenz M, Müller H, Schramm H et al (1998) Randomized trial of surgery versus surgery followed by adjuvant hepatic arterial infusion with 5-fluorouracil and folinic acid for liver metastases of colorectal cancer. Ann Surg 228:756–764PubMedCrossRef
45.
go back to reference Onaitis M, Morse M, Hurwitz H et al (2003) Adjuvant hepatic arterial chemotherapy following metastasectomy in patients with isolated liver metastases. Ann Surg 237:782–789PubMedCrossRef Onaitis M, Morse M, Hurwitz H et al (2003) Adjuvant hepatic arterial chemotherapy following metastasectomy in patients with isolated liver metastases. Ann Surg 237:782–789PubMedCrossRef
46.
go back to reference Kemeny NE, Niedzwiecki D, Hollis DR et al (2006) Hepatic arterial infusion versus systemic therapy for hepatic metastases from colorectal cancer: a randomized trial of efficacy, quality of life, and molecular markers (CALGB 9481). J Clin Oncol 24:1395–1403PubMedCrossRef Kemeny NE, Niedzwiecki D, Hollis DR et al (2006) Hepatic arterial infusion versus systemic therapy for hepatic metastases from colorectal cancer: a randomized trial of efficacy, quality of life, and molecular markers (CALGB 9481). J Clin Oncol 24:1395–1403PubMedCrossRef
47.
go back to reference Kemeny N, Huang Y, Cohen AM et al (1999) Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer. N Engl J Med 341:2039–2048PubMedCrossRef Kemeny N, Huang Y, Cohen AM et al (1999) Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer. N Engl J Med 341:2039–2048PubMedCrossRef
48.
go back to reference Benoist S, Brouquet A, Penna C et al (2006) Complete response of colorectal liver metastases after chemotherapy: does it mean cure? J Clin Oncol 24:3939–3945PubMedCrossRef Benoist S, Brouquet A, Penna C et al (2006) Complete response of colorectal liver metastases after chemotherapy: does it mean cure? J Clin Oncol 24:3939–3945PubMedCrossRef
Metadata
Title
Impact of the Degree of Liver Resection on Survival for Patients with Multiple Liver Metastases from Colorectal Cancer
Authors
Kuniya Tanaka
Hiroshi Shimada
Chizuru Matsumoto
Kenichi Matsuo
Kazuhisa Takeda
Yasuhiko Nagano
Shinji Togo
Publication date
01-09-2008
Publisher
Springer-Verlag
Published in
World Journal of Surgery / Issue 9/2008
Print ISSN: 0364-2313
Electronic ISSN: 1432-2323
DOI
https://doi.org/10.1007/s00268-008-9610-0

Other articles of this Issue 9/2008

World Journal of Surgery 9/2008 Go to the issue